FDG-PET/CT response assessment with qualitative Lugano criteria outperforms change in SUVmax as a predictive biomarker in frontline treatment of mantle cell lymphoma

FDG-PET/CT response assessment with qualitative Lugano criteria outperforms change in SUV_max as a predictive biomarker in frontline treatment of mantle cell lymphoma

Leuk Lymphoma. 2023 Nov-Dec;64(11):1870-1874. doi: 10.1080/10428194.2023.2239404. Epub 2023 Jul 25.

David A Russler-Germain¹, Brendan R Calhoun², Ningying Wu³, Marcus P Watkins¹, Barry A Siegel^{2

4}, Nancy L Bartlett^{1

4}, Joyce C Mhlanga²

¹ Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States.
² Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, United States.
³ Public Health Sciences Division, Department of Surgery, Washington University School of Medicine, St. Louis, MO, United States.
⁴ Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, United States.

No abstract available